Gabapentin use and a claim for memory loss in California

California leads the nation in total gabapentin prescriptions, with an estimated 8 to 9 million annual prescriptions dispensed across the state's 39 million residents. The state's massive healthcare infrastructure — including academic medical centers at UCLA, UCSF, Stanford, and UC San Diego — provides diagnostic resources for identifying gabapentin-induced cognitive decline, but the sheer volume of prescribing means hundreds of thousands of Californians may be at risk. California has not scheduled gabapentin as a controlled substance, though the state's CURES prescription monitoring program tracks dispensing. The state's plaintiff-friendly courts, particularly in Los Angeles and San Francisco, make it a premier jurisdiction for pharmaceutical litigation, and California's JCCP coordination process enables efficient management of mass gabapentin claims.

For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for California.